JOSE
SCHNEIDER FONTAN
Investigador en el periodo 2015-2024
Publicaciones (28) Publicaciones de JOSE SCHNEIDER FONTAN
2024
-
Colposcopically Directed Biopsy Before Ablative Treatment Versus Direct Ablative Treatment in Patients With Cervical Oncogenic HPV
Cancer Diagnosis and Prognosis, Vol. 4, Núm. 4, pp. 430-433
2023
-
CD44-targeted nanoparticles for co-delivery of docetaxel and an Akt inhibitor against colorectal cancer
Biomaterials Advances, Vol. 154
-
Ki67 and E-cadherin Are Independent Predictors of Long-term Survival in Endometrial Carcinoma
Anticancer Research, Vol. 43, Núm. 2, pp. 683-687
2022
-
Breast Cancer Stem Cells: A Clinician's View
Methods in molecular biology (Clifton, N.J.), Vol. 2471, pp. 345-349
-
In Vivo Effects of Conditioned Medium from Human Uterine Cervical Stem Cells in an Ovarian Cancer Xenograft Mouse Model
Cancer genomics & proteomics, Vol. 19, Núm. 5, pp. 570-575
-
Thematic analysis of illness narratives as an example of an approach to better understand the lived experience of women diagnosed with breast cancer in Spain
BMJ open, Vol. 12, Núm. 10, pp. e060935
2021
-
Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation
International Journal of Pharmaceutics, Vol. 599
-
Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses
Cellular and Molecular Life Sciences, Vol. 78, Núm. 2, pp. 447-467
-
Joint tumor bud–mmp/timp count at the invasive front improves the prognostic evaluation of invasive breast carcinoma
Biomedicines, Vol. 9, Núm. 2, pp. 1-15
-
Low birth weight trends in Organisation for Economic Co-operation and Development countries, 2000–2015: economic, health system and demographic conditionings
BMC Pregnancy and Childbirth, Vol. 21, Núm. 1
2019
-
Breast cancer tumor stroma: Cellular components, phenotypic heterogeneity, intercellular communication, prognostic implications and therapeutic opportunities
Cancers, Vol. 11, Núm. 5, pp. 1-26
-
Corrigendum: Antifungal activity of the human uterine cervical stem cells conditioned medium (hUCESC-CM) against candida albicans and other medically relevant species of candida (Frontiers in Microbiology (2018) 9 (2818) DOI: 10.3389/fmicb.2018.02818)
Frontiers in Microbiology
-
Mesenchymal stem cells in homeostasis and systemic diseases: Hypothesis, evidences, and therapeutic opportunities
International Journal of Molecular Sciences, Vol. 20, Núm. 15
-
Normalized second and fourth finger lengths in male and female partners and IVF cycle outcomes
Reproductive BioMedicine Online, Vol. 38, Núm. 5, pp. 808-815
-
Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome
Oncotarget, Vol. 10, Núm. 20, pp. 1918-1931
-
“Ductal carcinoma in situ”: The curse of a name
Revista de Senologia y Patologia Mamaria
2018
-
Antifungal activity of the human uterine cervical stem cells conditioned medium (hUCESC-CM) against candida albicansand other medically relevant species of candida
Frontiers in Microbiology, Vol. 9, Núm. NOV
-
Mammographic screening: the beginning of the end?
Revista de Senologia y Patologia Mamaria
-
Non pregnant human uterus as source of mesenchymal stem cells
Current Stem Cell Research and Therapy, Vol. 13, Núm. 6, pp. 423-431
2017
-
A Prospective Randomized Trial of Postural Changes vs Passive Supine Lying during the Second Stage of Labor under Epidural Analgesia
Medical sciences (Basel, Switzerland), Vol. 5, Núm. 1